Rivaroxaban, Anti Xa
Test Catalog Information
| Test Catalog Synonyms |
|
| EPIC Synonyms |
ANTIXA Xerelto |
| Cerner Primary Mnemonic | Rivaroxaban |
| EPIC Display Name | Rivaroxaban, Anti Xa |
| Allscripts (AEHR) Order Name | Rivaroxaban (Xarelto) |
| Sunrise Clinical Manager (SCM) Order Name | Rivaroxaban (Xarelto) Level |
| EPIC Inpatient Orderable | Yes |
| EPIC Outpatient Orderable | Yes |
| Cerner Results |
RIVAROX |
| Clinical Info |
Rivaroxaban is an oral factor Xa inhibitor that is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also indicated for the treatment, prophylaxis, or the reduction in the risk of reoccurrence of deep vein thrombosis (DVT) or pulmonary embolism (PE). Rivaroxaban does not need to be monitored routinely, however, exceptions may include determination of failure of therapy vs. poor compliance, or potential dose adjustment required for renal or hepatic dysfunction. |
| Specimen Type |
Blood |
| Container |
Blue Top Tube |
| Collection Instructions |
Container/Tube: 3.2 % Light blue Top (sodium citrate) tube Specimen: 1 mL plasma (0.5 ml min) transport Temperature: Frozen Patient Preparation: Collect samples 2 - 4 hours post dose (peak) Set Up Monday, Wednesday and Friday TAT: 2 - 3 Days |
| Transport Instructions |
Frozen |
| Specimen Stability | |
| Methodology |
Chromogenic |
| Days Performed | |
| Performing Laboratory |
Quest Diagnostics' Nichols Institute, Inc. - Chantilly |
| CPT |
80299 LOINC Code - 72624-0 |
| PDM |
1759180 |
Desired Epic Build Rivaroxaban, Anti Xa
| Cerner Primary Mnemonic: | Rivaroxaban | ||||||
| PDM | 1759180 | ||||||
| Informatics - Workgroup | Hematology | ||||||
| Synonyms * | ANTIXA Xerelto | ||||||
| Display Name * | Rivaroxaban, Anti Xa | ||||||
| Order Entry Specimen Sources * | |||||||
| Order Entry Specimen Types |
Blood
| ||||||
| Specimen Navigator Specimen Types | |||||||
| Specimen Navigator Specimen Sources | |||||||
| Specimen Navigator Short Name | |||||||
| Ordering info (EPIC SmartText) | Rivaroxaban is an oral factor Xa inhibitor that is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also indicated for the treatment, prophylaxis, or the reduction in the risk of reoccurrence of deep vein thrombosis (DVT) or pulmonary embolism (PE). Rivaroxaban does not need to be monitored routinely, however, exceptions may include determination of failure of therapy vs. poor compliance, or potential dose adjustment required for renal or hepatic dysfunction. | ||||||
| IP Orderable | Yes | ||||||
| OP Orderable | Yes | ||||||
|
AOEs * | |||||||
| AP AOEs | |||||||
| Special History | No | ||||||
| Build Comments | |||||||
| Filter * | |||||||
| Procedure Category Change | |||||||
Cerner Results
| |||||||
Current Actual EPIC Build as of 10/28/2024
| Procedure Id | 114760 | ||||||||||||
| Pdm | 1759180 | ||||||||||||
| Order Display Name | Rivaroxaban, Anti Xa | ||||||||||||
| Procedure Name | RIVAROXABAN (XARELTO) LEVEL | ||||||||||||
| Procedure Master Number | LAB11192 | ||||||||||||
| Short Procedure Name | RIVAROXABAN (XARELTO) LEVEL | ||||||||||||
| Category Code | 1.0 | ||||||||||||
| Category Code Record Name | LAB BLOOD ORDERABLES | ||||||||||||
| Synonyms | ANTIXA XERELTO | ||||||||||||
| Clinically Active | Yes | ||||||||||||
| Orderable | Yes | ||||||||||||
| Performable | Yes | ||||||||||||
| Filter Genomics | |||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/114760 | ||||||||||||
| Ordering Instructions | |||||||||||||
| Default Specimen Type | Blood | ||||||||||||
| Specimen Type Pick List | Blood | ||||||||||||
| Specimen Type List | |||||||||||||
| Op Specimen Type List | |||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||
| Specimen Source Default - Male | Blood, Venous | ||||||||||||
| Specimen Source Default - Female | Blood, Venous | ||||||||||||
| Specimen Source List | |||||||||||||
| Op Specimen Source List | |||||||||||||
| Ip Lab Test Components For Report | |||||||||||||
| Op Lab Test Components For Report | |||||||||||||
| Order Questions | [] | ||||||||||||
| Order Questions Record Name | |||||||||||||
| Inpatient Order Questions | [] | ||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||
| Order Specific Question Override | |||||||||||||
| Inpatient Question Override | |||||||||||||
| Location Restrict List Ip | |||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||
| Location Restrict List Include Ip | |||||||||||||
| Location Restrict List Op | |||||||||||||
| Location Restrict List Op Record Name | |||||||||||||
| Location Restrict List Includes Op | |||||||||||||
| Edp Amb Order Specific Questions Record Name | |||||||||||||
| Edp Ip Order Specific Questions Record Name | |||||||||||||
| Edp Ip Specimen Source | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary | ||||||||||||
| Edp Op Specimen Source | |||||||||||||
| Edp Ip Specimen Type | Blood | ||||||||||||
| Edp Op Specimen Type | |||||||||||||
| Derived Edp Ip Buttons S | Blood, Central Line Blood, Venous Blood, Capillary Blood, Arterial | ||||||||||||
| Derived Edp Ip Buttons T | Blood | ||||||||||||
| Derived Edp Op Buttons S | |||||||||||||
| Derived Edp Op Buttons T | |||||||||||||
| Ip Orderable | 1 | ||||||||||||
| Op Orderable | 1 | ||||||||||||
| EPIC OP AOEs | |||||||||||||
| EPIC IP AOEs | |||||||||||||
EPIC Components (results)
| |||||||||||||